2-[(18)F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study

Purpose To evaluate the role of 2-[(18)F]FDGPET/CT in the follow-up of radioiodine refractory thyroid cancer (RR-TC). Methods Forty-six 2-[(18)F]FDGPET/CT scans from 14 RR-TC patients were considered. Thyroid function tests: thyroglobulin (Tg), levothyroxine (LT4), and tyrosine-kinases inhibitors (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Gay, Stefano, Raffa, Stefano, De’Luca di Pietralata, Anna, Bauckneht, Matteo, Vera, Lara, Miceli, Alberto, Albertelli, Manuela, Morbelli, Silvia, Giusti, Massimo, Ferone, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870858/
https://www.ncbi.nlm.nih.gov/pubmed/35204596
http://dx.doi.org/10.3390/diagnostics12020506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870858/
https://www.ncbi.nlm.nih.gov/pubmed/35204596
http://dx.doi.org/10.3390/diagnostics12020506

Ejemplares similares